KBC Private Equity NV [t] +32 (0)2 429 36 45
  Havenlaan 12 [f] +32 (0)2 429 05 25
address   1080 Brussels - Belgium [e] info@kbcpe.be


WELCOME TO KBC PRIVATE EQUITY

THE PRIVATE EQUITY FINANCIER OF KBC GROUP

This website explains the strategy of the private equity company of the KBC Group.
An overview of the portfolio is included.

 

NEWS

  • KBC Private Equity and Cellumat's management team increase capital in Cellumat
  • Biocartis raises 10 million euros in Series A financing round
  • arGEN-X raises 9.5 million euros to put SIMPLE Antibody platform to work
  • KBC Arkiv invests in expansion of LCL Belgium data center
  • Aristo Music receives capital injection of 2.6 million euros
  • Sofiproteol acquires 100% of the OLEON group
  • Okapi Sciences concludes successful first financing round of 8.5 million euros
  • Saffelberg Investments, Biovest and KBC Private Equity to invest 6.5 million euros in biotech company PharmaNeuroBoost (PNB)
  • KBC Arkiv invests in Fugeia
  • KBC Private Equity invests in Vemedia
  • KBC Private Equity sells its stake in Corelio

read more on the "News" page

 


© KBC Private Equity 2005 - Legal disclaimer - Created by The Reference
Brussels Budapest Prague Warsaw Boekarest Belgrade